| pubmed-article:9594875 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9594875 | lifeskim:mentions | umls-concept:C0007131 | lld:lifeskim |
| pubmed-article:9594875 | lifeskim:mentions | umls-concept:C1519670 | lld:lifeskim |
| pubmed-article:9594875 | lifeskim:mentions | umls-concept:C1514475 | lld:lifeskim |
| pubmed-article:9594875 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:9594875 | pubmed:dateCreated | 1998-6-10 | lld:pubmed |
| pubmed-article:9594875 | pubmed:abstractText | Recent evidence suggests that tumor angiogenesis is associated with patient outcome in a number of malignancies. However, little is known about the significance of tumor microvessel density as evaluated by an anti-CD34 antibody in patients with lung cancer. | lld:pubmed |
| pubmed-article:9594875 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9594875 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9594875 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9594875 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:9594875 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9594875 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9594875 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9594875 | pubmed:month | May | lld:pubmed |
| pubmed-article:9594875 | pubmed:issn | 0003-4975 | lld:pubmed |
| pubmed-article:9594875 | pubmed:author | pubmed-author:SasakiMM | lld:pubmed |
| pubmed-article:9594875 | pubmed:author | pubmed-author:TanakaHH | lld:pubmed |
| pubmed-article:9594875 | pubmed:author | pubmed-author:ChibaYY | lld:pubmed |
| pubmed-article:9594875 | pubmed:author | pubmed-author:TanigawaNN | lld:pubmed |
| pubmed-article:9594875 | pubmed:author | pubmed-author:MatsuyamaKK | lld:pubmed |
| pubmed-article:9594875 | pubmed:author | pubmed-author:MuraokaRR | lld:pubmed |
| pubmed-article:9594875 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9594875 | pubmed:volume | 65 | lld:pubmed |
| pubmed-article:9594875 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9594875 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9594875 | pubmed:pagination | 1405-9 | lld:pubmed |
| pubmed-article:9594875 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
| pubmed-article:9594875 | pubmed:meshHeading | pubmed-meshheading:9594875-... | lld:pubmed |
| pubmed-article:9594875 | pubmed:meshHeading | pubmed-meshheading:9594875-... | lld:pubmed |
| pubmed-article:9594875 | pubmed:meshHeading | pubmed-meshheading:9594875-... | lld:pubmed |
| pubmed-article:9594875 | pubmed:meshHeading | pubmed-meshheading:9594875-... | lld:pubmed |
| pubmed-article:9594875 | pubmed:meshHeading | pubmed-meshheading:9594875-... | lld:pubmed |
| pubmed-article:9594875 | pubmed:meshHeading | pubmed-meshheading:9594875-... | lld:pubmed |
| pubmed-article:9594875 | pubmed:meshHeading | pubmed-meshheading:9594875-... | lld:pubmed |
| pubmed-article:9594875 | pubmed:meshHeading | pubmed-meshheading:9594875-... | lld:pubmed |
| pubmed-article:9594875 | pubmed:meshHeading | pubmed-meshheading:9594875-... | lld:pubmed |
| pubmed-article:9594875 | pubmed:meshHeading | pubmed-meshheading:9594875-... | lld:pubmed |
| pubmed-article:9594875 | pubmed:meshHeading | pubmed-meshheading:9594875-... | lld:pubmed |
| pubmed-article:9594875 | pubmed:meshHeading | pubmed-meshheading:9594875-... | lld:pubmed |
| pubmed-article:9594875 | pubmed:meshHeading | pubmed-meshheading:9594875-... | lld:pubmed |
| pubmed-article:9594875 | pubmed:meshHeading | pubmed-meshheading:9594875-... | lld:pubmed |
| pubmed-article:9594875 | pubmed:meshHeading | pubmed-meshheading:9594875-... | lld:pubmed |
| pubmed-article:9594875 | pubmed:meshHeading | pubmed-meshheading:9594875-... | lld:pubmed |
| pubmed-article:9594875 | pubmed:meshHeading | pubmed-meshheading:9594875-... | lld:pubmed |
| pubmed-article:9594875 | pubmed:meshHeading | pubmed-meshheading:9594875-... | lld:pubmed |
| pubmed-article:9594875 | pubmed:meshHeading | pubmed-meshheading:9594875-... | lld:pubmed |
| pubmed-article:9594875 | pubmed:meshHeading | pubmed-meshheading:9594875-... | lld:pubmed |
| pubmed-article:9594875 | pubmed:meshHeading | pubmed-meshheading:9594875-... | lld:pubmed |
| pubmed-article:9594875 | pubmed:meshHeading | pubmed-meshheading:9594875-... | lld:pubmed |
| pubmed-article:9594875 | pubmed:meshHeading | pubmed-meshheading:9594875-... | lld:pubmed |
| pubmed-article:9594875 | pubmed:meshHeading | pubmed-meshheading:9594875-... | lld:pubmed |
| pubmed-article:9594875 | pubmed:meshHeading | pubmed-meshheading:9594875-... | lld:pubmed |
| pubmed-article:9594875 | pubmed:year | 1998 | lld:pubmed |
| pubmed-article:9594875 | pubmed:articleTitle | Tumor angiogenesis as a prognostic marker in operable non-small cell lung cancer. | lld:pubmed |
| pubmed-article:9594875 | pubmed:affiliation | Second Department of Surgery, Fukui Medical School, Japan. | lld:pubmed |
| pubmed-article:9594875 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9594875 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9594875 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9594875 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9594875 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9594875 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9594875 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9594875 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9594875 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9594875 | lld:pubmed |
